Search Results

PCI 29732 1 mg  | 99.79%

TargetMol

PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.

More Information Supplier Page

PCI 29732 25 mg  | 99.79%

TargetMol

PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.

More Information Supplier Page

PCI 29732 10 mg  | 99.79%

TargetMol

PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.

More Information Supplier Page

PCI 29732 5 mg  | 99.79%

TargetMol

PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.

More Information Supplier Page

PCI 29732 2 mg  | 99.79%

TargetMol

PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.

More Information Supplier Page

Capmatinib 2HCl 100 mg  | Purity Not Available

TargetMol

INCB-28060(free base) is a novel, ATP-competitive inhibitor of c-MET kinase with an IC50 with 0.13 nM.INCB28060 exhibits picomolar enzymatic potency and is highly specific for c-MET with more than 10, 000-fold selectivity over a large panel of human kinases. This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor […]

More Information Supplier Page